| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| AM | Acetoxymethyl |
| AxCa | Aberrant extra-large Ca2+ signal |
| AxD | Alexander disease |
| CSD | Cortical spreading depression |
| DS | Down syndrome |
| EAE | Experimental autoimmune encephalitis |
| ER | Endoplasmic reticulum |
| GAT-3 | GABA transporter 3 |
| GECI | Genetically encoded Ca2+ indicator |
| GFAP | Glial fibrillary acidic protein |
| GqPCR | Gq-protein coupled receptor |
| hPMCA2w/b | Human PMCA2w/b |
| IP3R2 | Inositol-1,4,5 trisphosphate receptor type2 |
| IP3R2KO | IP3R type2 knockout |
| MCAO | Middle cerebral artery occlusion |
| mGluR5 | Metabotropic glutamate receptor 5 |
| MSN | Medium spiny neuron |
| mPTP | Mitochondrial permeability transition pore |
| MS | Multiple sclerosis |
| OGD | Oxygen glucose deprivation |
| PID | Peri-infarct depolarization |
| RTT | Rett syndrome |
| SCI | Spinal cord injury |
| SE | Status epilepticus |
| SIC | Slow inward current |
| TBI | Traumatic brain injury |
| TSP1 | Thrombospondin 1 |